Hiba Elaasar
Neurology with Special Qualifications in Child Neurology · East Lansing, MINPI 1710507389
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,549 and has fallen 69.0% since, to $480 in 2025.
Across 104 payments — averaging $30.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$714
- Jazz Pharmaceuticals Inc.$389
- Neurelis, Inc.$349
- Biogen$228
- SK Life Science, Inc.$218
- Sarepta Therapeutics, Inc.$194
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,215100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 15 | $714 |
| Jazz Pharmaceuticals Inc. | 14 | $389 |
| Neurelis, Inc. | 10 | $349 |
| Biogen | 10 | $228 |
| SK Life Science, Inc. | 9 | $218 |
| Sarepta Therapeutics, Inc. | 10 | $194 |
| Immedica Pharma US, Inc. | 5 | $131 |
| Acadia Pharmaceuticals Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $112 |
| AbbVie | 1 | $101 |
| Catalyst Pharmaceuticals, Inc. | 3 | $93 |
| Genentech USA, Inc. | 3 | $75 |
| ITF Therapeutics LLC | 2 | $61 |
| NS Pharma, Inc. | 3 | $58 |
| Eisai Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Upsher-smith Laboratories LLC | 1 | $36 |
| Biomarin Pharmaceutical Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $29 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $27 |
| Sanofi | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $25 |
| Aucta Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,215 in reported general payments places this provider in the 80th percentile of 62 neurology with special qualifications in child neurology providers in Michigan.
See all neurology with special qualifications in child neurology providers in Michigan →
Other neurology with special qualifications in child neurology in East Lansing
- Suad KhalilEast Lansing$146K
- Ira DymeEast Lansing$2K
- Kabelo ThusangEast Lansing$633
- Gyula AcsadiDetroit$86K
- Daniel ArndtWest Bloomfield$62K
- Michelle FigueroaDetroit$57K
- Christopher AllenSaginaw$38K
- Kheir Al-ZouhayliTroy$32K
- Jena KruegerGrand Rapids$22K
- Seth DevriesGrand Rapids$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.